Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1985-6-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0278-2677
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
204-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2985326-Carcinoma, Small Cell,
pubmed-meshheading:2985326-Carcinoma, Squamous Cell,
pubmed-meshheading:2985326-Drug Therapy, Combination,
pubmed-meshheading:2985326-Etidronic Acid,
pubmed-meshheading:2985326-Humans,
pubmed-meshheading:2985326-Hypercalcemia,
pubmed-meshheading:2985326-Lung Neoplasms,
pubmed-meshheading:2985326-Plicamycin
|
pubmed:articleTitle |
Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodium.
|
pubmed:publicationType |
Journal Article
|